$1.73Billion– No. of Holdings #47
Cormorant Asset Management, LP has about 81.9% of it's holdings in Healthcare sector.
Sector | % |
---|---|
Healthcare | 81.9 |
Others | 18.1 |
Cormorant Asset Management, LP has about 3.8% of it's portfolio invested in the large-cap and mega-cap stocks.
Category | % |
---|---|
MID-CAP | 48 |
SMALL-CAP | 25.9 |
UNALLOCATED | 20.7 |
LARGE-CAP | 3.8 |
MICRO-CAP | 1.4 |
About 45.6% of the stocks held by Cormorant Asset Management, LP either belong to S&P 500 or RUSSELL 2000 index.
Index | % |
---|---|
Others | 54.4 |
RUSSELL 2000 | 45.6 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
Cormorant Asset Management, LP has 47 stocks in it's portfolio. About 58.5% of the portfolio is in top 10 stocks. EYPT proved to be the most loss making stock for the portfolio. INSM was the most profitable stock for Cormorant Asset Management, LP last quarter.
Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
---|---|---|---|---|---|---|---|---|
ACLX | arcellx inc | 4.86 | 1,525,000 | 84,164,800 | reduced | -14.33 | ||
AGLE | spyre therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
ALPN | alpine immune sciences inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
ALXO | alx oncology hldgs inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
APLS | apellis pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
ARQT | arcutis biotherapeutics inc | 1.36 | 2,525,000 | 23,482,500 | added | 18.82 | ||
ATXS | astria therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
AUTL | autolus therapeutics plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
AVTE | aerovate therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
AXSM | axsome therapeutics inc | 1.86 | 400,000 | 32,200,000 | new | |||
BBIO | bridgebio pharma inc | 2.72 | 1,858,350 | 47,072,000 | reduced | -41.98 | ||
BCAB | bioatla inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
BMEA | biomea fusion inc | 0.93 | 3,570,870 | 16,068,900 | unchanged | 0.00 | ||
CABA | cabaletta bio inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
CGEM | cullinan therapeutics inc | 1.13 | 1,125,000 | 19,620,000 | new | |||
CMPX | compass therapeutics inc | 0.12 | 2,030,820 | 2,030,820 | reduced | -63.48 | ||
CNTA | centessa pharmaceuticals plc | 0.84 | 1,611,600 | 14,552,700 | added | 186 | ||
CRBP | corbus pharmaceuticals hldgs | 5.29 | 2,025,000 | 91,631,200 | unchanged | 0.00 | ||
CRNX | crinetics pharmaceuticals in | 3.49 | 1,350,000 | 60,466,500 | added | 17.39 | ||
EWTX | edgewise therapeutics inc | 3.13 | 3,006,530 | 54,147,700 | unchanged | 0.00 | ||